Description of Collaborative Activity: |
The Antiviral Program for Pandemics (APP) aims to develop safe and effective antivirals to combat SARS-CoV-2, the virus that causes COVID-19, as well as to build sustainable platforms for targeted drug discovery and development of a robust pipeline of antivirals against viruses with pandemic potential. |
NIH Participating Institutes/Centers/Office of the Director: |
NIAID, NCATS, OD/DPCPSI/ORIP |
